IL17A and autoimmune disease: At the effector stage of EAU or other autoimmune diseases, high levels of interferon-γ (IFN-γ) or interleukin 17 (IL-17), produced by T-helper type 1 (Th1) or Th17 cells, were believed to be critically pathogenic [2,4,5].